Skip to main content
SpringerLink
Log in

Dermatoses Most Frequently Related to Diabetes Mellitus

  • Chapter
  • First Online:
Book cover Dermatology and Diabetes

  • 1182 Accesses

Abstract

There are some dermatoses that are more frequent in diabetics than in the general population, like Vitiligo, Bullous Pemphigoid, Porphyria cutanea tarda, among others. The question is why they are related to Diabetes and which is the underlying linking mechanism? Herein, we propose a classification of these group of dermatoses, based on the possible explanation of this relationship. Moreover, we observe that Diabetes impacts negatively on the evolution, response to treatment, etc. of these dermatoses.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 79.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 99.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 129.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Cohen Sabban E. Enfermedades que se asocian con frecuencia a la Diabetes. En: Prof. Dr. Horacio Cabo (ed). Manifestaciones Cutáneas de la Diabetes Mellitus. Bueno Aires: Ed A. Macchi; 1996. p. 139–163.

    Google Scholar 

  2. Cohen Sabban E, Cabo H. Dermatoses most frequently related to diabetes. J Clin Dermatol. 1999;2:15–22.

    Google Scholar 

  3. Muñoz-Santos C, Guilabert A, Moreno N, Gimenez M, Darwich E, To-Figueras J, Herrero C. The association between porphyria cutanea tarda and diabetes mellitus: analysis of a long-term follow-up cohort. Br J Dermatol. 2011;165:486–91.

    Article  PubMed  Google Scholar 

  4. Kashif M, Kumar H, Khaja M. An unusual presentation of eruptive xanthoma: a case report and literature review. Medicine (Baltimore). 2016;95(37):e4866.

    Article  Google Scholar 

  5. Wani AM, Hussain WM, Fatani MI, et al. Eruptive xanthomas with Koebner phenomenon, type 1 diabetes mellitus, hypertriglyceridaemia and hypertension in a 41-year-old man. BMJ Case Rep. 2009;2009. https://doi.org/10.1136/bcr.05.2009.1871.

  6. Kala J, Mostow EN. Images in clinical medicine. Eruptive xanthoma. N Engl J Med. 2012;366:835.

    Article  PubMed  Google Scholar 

  7. Abdelghany M, Massoud S. Eruptive xanthoma. Cleve Clin J Med. 2015;82(4):209–10. https://doi.org/10.3949/ccjm.82a.14081.

    Article  PubMed  Google Scholar 

  8. Guerrero Vázquez R, Oliva Rodríguez R, Cuenca Cuenca JI, Sánchez Alberdi F, Navarro González E. Malignant glucagonoma: an uncommon cause of new onset diabetes. Endocrinol Nutr. 2011;58:199–201.

    Article  PubMed  Google Scholar 

  9. Halvorson SAC, Gilbert E, Hopkins RS, Liu H, Lopez C, Chu M, Martin M, Sheppard B. Putting the pieces together: necrolytic migratory erythema and the glucagonoma syndrome. J Gen Intern Med. 2013;28(11):1525–9.

    Article  PubMed  PubMed Central  Google Scholar 

  10. John AM, Schwartz RA. Glucagonoma syndrome: a review and update on treatment. J Eur Acad Dermatol Venereol. 2016;30(12):2016–22.

    Article  CAS  PubMed  Google Scholar 

  11. Granero Castro P, Miyar de León A, Granero Trancón J, Álvarez Martínez P, Álvarez Pérez JA, Fernández Fernández JC, García Bernardo CM, Barneo Serra L, González González JJ. Glucagonoma syndrome: a case report. J Med Case Rep. 2011;5:402.

    Article  Google Scholar 

  12. Ko MJ, Chiu HC, Jee SH, et al. Postprandial blood glucose is associated with generalized pruritus in patients with type 2 diabetes. Eur J Dermatol. 2013;23(5):688–93.

    PubMed  Google Scholar 

  13. Vinik A. Barely scratching the surface. Diabetes Care. 2010;33(1):210–2.

    Article  PubMed  PubMed Central  Google Scholar 

  14. Horton WB, Boler PL, Subauste AR. Diabetes mellitus and the skin: recognition and management of cutaneous manifestations. South Med J. 2016;109(10):636–46.

    PubMed  Google Scholar 

  15. Atabek ME, Akyürek N, Eklioglu BS. Frequency of vagınal candida colonization and relationship between metabolic parameters in children with type 1 diabetes mellitus. J Pediatr Adolesc Gynecol. 2013;26(5):257–60.

    Article  PubMed  Google Scholar 

  16. Yamaoka H, Sasaki H, Yamasaki H, Ogawa K, Ohta T, Furuta H, Nishi M, Nanjo K. Truncal pruritus of unknown origin may be a symptom of diabetic polyneuropathy. Diabetes Care. 2010;33(1):150–5.

    Article  PubMed  PubMed Central  Google Scholar 

  17. Vasapollo P, Cione E, Luciani F, Gallelli L. Generalized intense pruritus during canaglifozina treatment: Is it an adverse drug reaction? Curr Drug Saf. 2016.

    Google Scholar 

  18. Baselga Torres E, Torres-Pradilla M. Manifestaciones cutáneas en niños con diabetes mellitus y obesidad. Actas Dermosifiliogr. 2014;105:546–57.

    Article  CAS  PubMed  Google Scholar 

  19. Shah R, Jindal A, Patel N. Acrochordons as a cutaneous sign of metabolic syndrome: a case-control study. Ann Med Health Sci Res. 2014;4(2):202–5.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Barbato MT, Criado PR, Silva AK, Averbeck E, Guerine MB, Sá NB. Association of acanthosis nigricans and skin tags with insulin resistance. An Bras Dermatol. 2012;87(1):97–104.

    Article  PubMed  Google Scholar 

  21. Boniface K, Taïeb A, Seneschal J. New insights into immune mechanisms of vitiligo. G Ital Dermatol Venereol. 2016;151(1):44–54.

    PubMed  Google Scholar 

  22. Mendes AL, Miot HA, Junior HV. Diabetes mellitus and the skin. An Bras Dermatol. 2017;92(1):8–20.

    Article  PubMed  PubMed Central  Google Scholar 

  23. Sheth VM, Guo Y, Qureshi AA. Comorbidities associated with vitiligo: a ten-year retrospective study. Dermatology. 2013;227(4):311–5.

    Article  PubMed  Google Scholar 

  24. Furue M, Kadono T. Bullous pemphigoid: What’s ahead? J Dermatol. 2015;43(3):237–40. https://doi.org/10.1111/1346-8138.13207.

    Article  PubMed  Google Scholar 

  25. Jedlickova H, Jana Racovska J, Niedermeier A, Feit J, Hertl M. Anti-basement membrane zone antibodies in elderly patients with pruritic disorders and diabetes mellitus. Eur J Dermatol. 2008;18(5):534–8.

    CAS  PubMed  Google Scholar 

  26. Kibsgaard L, Bay B, Deleuran M, Vestergaard C. A retrospective consecutive case-series study on the effect of systemic treatment, length of admission time, and co-morbidities in 98 bullous pemphigoid patients admitted to a tertiary centre. Acta Derm Venereol. 2015;95(3):307–11.

    Article  PubMed  Google Scholar 

  27. Sakanoue M, Kawai K, Kanekura T. Bullous pemphigoid associated with type 1 diabetes mellitus responsive to mycophenolate mofetil. J Dermatol. 2012;39(10):884–5.

    Article  PubMed  Google Scholar 

  28. Lee JH, Kim SC. Mortality of patients with bullous pemphigoid in Korea. J Am Acad Dermatol. 2014;71:676–83.

    Article  PubMed  Google Scholar 

  29. Cabo H, Cohen Sabban E. Psoriasis y Diabetes. Texto para libro con formato de Disco Compacto 2002. Autores: E. Chouela; A.Bessone; N. Poggio.

    Google Scholar 

  30. Napolitano M, Megna M, Monfrecola G. Insulin resistance and skin diseases. Sci World J. 2015;2015:479354.

    Article  Google Scholar 

  31. Vachatova S, Andrys C, Krejsek J, Salavec M, Ettler K, Rehacek V, Cermakova E, Malkova A, Fiala Z, Borska L. Metabolic syndrome and selective inflammatory markers in psoriatic patients. J Immunol Res. 2016;2016:5380792. https://doi.org/10.1155/2016/5380792.

    Article  PubMed  PubMed Central  Google Scholar 

  32. Balci A, Balci DD, Yonden Z, Korkmaz I, Yenin JZ, Celik E, Okumus N, Egilmez E. Increased amount of visceral fat in patients with psoriasis contributes to metabolic syndrome. Dermatology. 2010;220(1):32–7.

    Article  PubMed  Google Scholar 

  33. Carvalho AV, Romiti R, Souza CD, Paschoal RS, Milman LM, Meneghello LP. Psoriasis comorbidities: complications and benefits of immunobiological treatment. An Bras Dermatol. 2016;91(6):781–9.

    Article  PubMed  PubMed Central  Google Scholar 

  34. Daudén E, Castañeda S, Suárez C, García-Campayo J, Blasco AJ, Aguilar MD, Ferrándiz C, Puig L, Sánchez-Carazo JL. Abordaje integral de la comorbilidad del paciente con psoriasis. Actas Dermosifiliogr. 2012;103(Suppl 1):1–64.

    PubMed  Google Scholar 

  35. Shah K, Mellars L, Changolkar A, Feldman SR. Real-world burden of comorbidities in US patients with psoriasis. J Am Acad Dermatol. 2017;77:287–92.

    Article  PubMed  Google Scholar 

  36. Gupta S, Jawanda MK. Oral lichen planus: an update on etiology, pathogenesis, clinical presentation, diagnosis and management. Indian J Dermatol. 2015;60(3):222–9.

    Article  PubMed  PubMed Central  Google Scholar 

  37. Krupaa RJ, Sankari SL, Masthan KM, Rajesh E. Oral lichen planus: an overview. J Pharm Bioallied Sci. 2015;7(Suppl 1):S158–61.

    PubMed  PubMed Central  Google Scholar 

  38. Baykal L, Arıca DA, Yaylı S, Örem A, Bahadır S, Altun E, Yaman H. Prevalence of metabolic syndrome in patients with mucosal lichen planus: a case-control study. Am J Clin Dermatol. 2015;16(5):439–45.

    Article  PubMed  Google Scholar 

  39. Ghosh K, Das K, Ghosh S, Chakraborty S, Jatua SK, Bhattacharya A, Ghosh M. Prevalence of skin changes in diabetes mellitus and its correlation with internal diseases: a single center observational study. Indian J Dermatol. 2015;60(5):465–9.

    Article  PubMed  PubMed Central  Google Scholar 

  40. Mozaffari HR, Roohollah Sharifi R, Sadeghi M. Prevalence of oral lichen planus in diabetes mellitus: a meta-analysis study. Acta Inform Med. 2016;24(6):390–3.

    Article  PubMed  PubMed Central  Google Scholar 

  41. de la Puente Martín M, Pallardo Rodil B, Valverde Moyar MV, Fernández Guarino M, Barrio Garde J, Gómez-Pavón J. Classic Kaposi sarcoma. Rev Esp Geriatr Gerontol. 2015;50(4):200–5.

    Article  PubMed  Google Scholar 

  42. Mohanna S, Maco V, Bravo F, Gotuzzo E. Epidemiology and clinical characteristics of classic Kaposi’s sarcoma, seroprevalence, and variants of human herpesvirus 8 in South America: a critical review of an old disease. Int J Infect Dis. 2005;9:239–50.

    Article  PubMed  Google Scholar 

  43. Vassallo C, Carugno A, Derlino F, Ciocca O, Brazzelli V, Borroni G. Intralesional vinblastine injections for treatment of classic Kaposi sarcoma in diabetic patients. Cutis. 2015;95(5):E28–34.

    PubMed  Google Scholar 

  44. Anderson LA, Lauria C, Romano N, Brown EE, Whitby D, Graubard BI, Li Y, Messina A, Gafà L, Vitale F, Goedert JJ. Risk factors for classical Kaposi sarcoma in a population-based case-control study in Sicily. Cancer Epidemiol Biomark Prev. 2008;17(12):3435–43.

    Article  CAS  Google Scholar 

  45. Nair PA, Jivani NB, Diwan NG. Kyrle’s disease in a patient of diabetes mellitus and chronic renal failure on dialysis. J Family Med Prim Care. 2015;4(2):284–6.

    Article  PubMed  PubMed Central  Google Scholar 

  46. Wieczorek A, Matusiak L, Szepietowski JC. Acquired peforating dermatosis associated with end-stage diabetic kidney failure in a hemodialysis patient. Iran J Kidney Dis. 2016;10(3):164–7.

    PubMed  Google Scholar 

  47. Fernandes KA, Lima LA, Guedes JC, Lima RB, D'Acri AM, Martins CJ. Acquired perforating dermatosis in a patient with chronic renal failure. An Bras Dermatol. 2016;91(5 suppl 1):10–3.

    Article  PubMed  PubMed Central  Google Scholar 

  48. Ramirez-Fort MK, Khan F, Rosendahl CO, Mercer SE, Shim-Chang H, Levitt JO. Acquired perforating dermatosis: a clinical and dermatoscopic correlation. Dermatol Online J. 2013;19(7):18958.

    PubMed  Google Scholar 

  49. Saray D, Seçkin B, Bilezikçi B. Acquired perforating dermatosis: clinicopathological features in twenty-two cases. J Eur Acad Dermatol Venereol. 2006;20:679–88.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Dermatology Department, Instituto de Investigaciones Médicas A. Lanari, University of Buenos Aires (UBA), Buenos Aires, Argentina

    Emilia Noemí Cohen Sabban M.D.

Authors
  1. Emilia Noemí Cohen Sabban M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Emilia Noemí Cohen Sabban M.D. .

Editor information

Editors and Affiliations

  1. Dermatology Department, Instituto de Investigaciones Médicas A. Lanari, University of Buenos Aires (UBA), Buenos Aires, Argentina

    Emilia Noemí Cohen Sabban

  2. Division of Diabetology, Department of Medicine, University of Buenos Aires, Buenos Aires, Argentina

    Félix Miguel Puchulu

  3. Division of Endocrinology, Diabetes and Metabolism, The University of Florida, Gainesville, Florida, USA

    Kenneth Cusi

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer International Publishing AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Sabban, E.N.C. (2018). Dermatoses Most Frequently Related to Diabetes Mellitus. In: Cohen Sabban, E., Puchulu, F., Cusi, K. (eds) Dermatology and Diabetes. Springer, Cham. https://doi.org/10.1007/978-3-319-72475-1_11

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-72475-1_11

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-72474-4

  • Online ISBN: 978-3-319-72475-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation